ReviewFrontiers in oncology2022

Based on the Development and Verification of a Risk Stratification Nomogram: Predicting the Risk of Lung Cancer-Specific Mortality in Stage IIIA-N2 Unresectable Large Cell Lung Neuroendocrine Cancer Compared With Lung Squamous Cell Cancer and Lung Adenocarcinoma.

Ying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.